Projected Income Statement: GSK plc

Forecast Balance Sheet: GSK plc

balance-sheet-analysis-chart GSK-PLC
Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 25,722 20,780 19,838 17,197 15,040 13,824 11,688 8,486
Change - -19.21% -4.53% -13.31% -12.54% -8.09% -15.45% -27.4%
Announcement Date 05/02/20 03/02/21 09/02/22 01/02/23 31/01/24 - - -
1GBP in Million
Estimates

Cash Flow Forecast: GSK plc

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
CAPEX 1 1,265 1,226 1,172 1,143 1,314 1,378 1,467 1,545
Change - -3.08% -4.4% -2.47% 14.96% 4.85% 6.49% 5.29%
Free Cash Flow (FCF) 1 5,073 5,406 4,437 6,260 5,454 3,517 5,529 6,521
Change - 6.56% -17.92% 41.09% -12.88% -35.52% 57.21% 17.95%
Announcement Date 05/02/20 03/02/21 09/02/22 01/02/23 31/01/24 - - -
1GBP in Million
Estimates

Forecast Financial Ratios: GSK plc

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

        
EBITDA Margin (%) 35.46% 27.95% 33.21% 35.63% 38.36% 32.79% 34.36% 35.87%
EBIT Margin (%) 26.58% 26.12% 25.81% 27.8% 28.97% 28.89% 29.52% 31.34%
EBT Margin (%) 18.43% 20.43% 15.95% 19.19% 19.99% 15.48% 24.44% 26.88%
Net margin (%) 13.76% 16.86% 12.85% 51% 16.25% 11.79% 17.9% 19.25%
FCF margin (%) 15.03% 15.85% 13.01% 21.35% 17.98% 11.29% 17.11% 19.06%
FCF / Net Income (%) 109.21% 94.03% 101.19% 41.86% 110.67% 95.77% 95.62% 99.01%

Profitability

        
ROA 8.9% 7.18% 5.5% 8.08% 10.55% 8% 10.66% 11.28%
ROE 75.02% 44.39% 38.22% 43.85% 52.48% 45.36% 42.61% 41.23%

Financial Health

        
Leverage (Debt/EBITDA) 2.15x 2.18x 1.75x 1.65x 1.29x 1.35x 1.05x 0.69x
Debt / Free cash flow 5.07x 3.84x 4.47x 2.75x 2.76x 3.93x 2.11x 1.3x

Capital Intensity

        
CAPEX / Current Assets (%) 3.75% 3.6% 3.44% 3.9% 4.33% 4.42% 4.54% 4.51%
CAPEX / EBITDA (%) 10.57% 12.86% 10.34% 10.94% 11.29% 13.48% 13.22% 12.59%
CAPEX / FCF (%) 24.94% 22.68% 26.41% 18.26% 24.09% 39.17% 26.54% 23.69%

Items per share

        
Cash flow per share 1 1.999 2.094 1.962 1.813 1.67 1.605 1.799 2.131
Change - 4.79% -6.3% -7.63% -7.86% -3.91% 12.08% 18.45%
Dividend per Share 1 1 1 1 0.6125 0.58 0.6031 0.6431 0.6908
Change - 0% 0% -38.75% -5.31% 3.99% 6.63% 7.42%
Book Value Per Share 1 3.024 3.661 3.758 2.627 3.294 3.611 4.115 4.923
Change - 21.04% 2.65% -30.09% 25.38% 9.64% 13.93% 19.64%
EPS 1 1.158 1.426 1.082 3.662 1.216 0.899 1.409 1.602
Change - 23.22% -24.1% 238.29% -66.79% -26.07% 56.76% 13.65%
Nbr of stocks (in thousands) 3,959,572 3,982,185 4,006,383 4,060,999 4,076,145 4,080,500 4,080,500 4,080,500
Announcement Date 05/02/20 03/02/21 09/02/22 01/02/23 31/01/24 - - -
1GBP
Estimates
2024 *2025 *
P/E ratio 15.4x 9.81x
PBR 3.83x 3.36x
EV / Sales 2.24x 2.1x
Yield 4.36% 4.65%
More valuation ratios * Estimated data

EPS & Dividend

eps-dividend-chart GSK-PLC

Year-on-year evolution of the PER

evolution-chart GSK-PLC

Year-on-year evolution of the Yield

evolution-chart GSK-PLC
Trading Rating
Investor Rating
ESG Refinitiv
B
surperformance-ratings-light-chart GSK-PLCMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
13.83GBP
Average target price
18.17GBP
Spread / Average Target
+31.37%
Consensus

Quarterly revenue - Rate of surprise